
Penguin Solutions Reports Q3 Fiscal 2025 Financial Results
Third Quarter Fiscal 2025 Highlights
Net sales of $324 million, up 7.9% versus the year-ago quarter
GAAP gross margin of 29.3%, down 30 basis points versus the year-ago quarter
Non-GAAP gross margin of 31.7%, down 60 basis points versus the year-ago quarter
GAAP diluted EPS of $(0.01) versus $0.10 in the year-ago quarter
Non-GAAP diluted EPS of $0.47 versus $0.37 in the year-ago quarter
'We delivered solid third quarter results while executing against our strategic objectives,' said Mark Adams, chief executive officer of Penguin Solutions. 'We also strengthened our balance sheet through a refinancing after the close of Q3, and we remain focused on developing our AI software and services capabilities, expanding go-to-market resources, and driving long-term value for our stockholders.'
Quarterly Financial Results
(1)
GAAP represents U.S. Generally Accepted Accounting Principles.
(2)
Non-GAAP represents GAAP excluding the impact of certain activities. Further information regarding the Company's use of non-GAAP measures and reconciliations between GAAP and non-GAAP measures are included within this press release.
Expand
Business Outlook
As of July 8, 2025, Penguin Solutions is providing the following financial outlook for fiscal year 2025:
Non-GAAP adjustments (in millions)
(A) Stock-based compensation and amortization of acquisition-related intangibles included in cost of sales
$
31
(B) Stock-based compensation and amortization of acquisition-related intangibles included in R&D and SG&A
48
(C) Goodwill Impairment
16
(D) Loss on extinguishment of debt
3
(E) Other adjustments
16
(F) Estimated income tax effects
(11
)
(G) Estimated effect of allocation of earnings to participating securities
(8
)
$
95
Expand
Prior Outlook
GAAP
Outlook
Adjustments
Non-GAAP
Outlook
Net sales
17% YoY Growth +/- 3%
—
17% YoY Growth +/- 3%
Gross margin
29% +/- 1%
2%
(A)
31% +/- 1%
Operating expenses
$336 million +/- $5 million
($71) million
(B)(C)(D)
$265 million +/- $5 million
Diluted earnings per share
-$0.02+/-$0.10
$1.62
(A)(B)(C)(D)(E)
$1.60 +/- $0.10
Diluted shares
54 million
1 million
55 million
Expand
Non-GAAP adjustments (in millions)
(A) Stock-based compensation and amortization of acquisition-related intangibles included in cost of sales
$
31
(B) Stock-based compensation and amortization of acquisition-related intangibles included in R&D and SG&A
48
(C) Goodwill impairment
16
(D) Other adjustments
7
(E) Estimated income tax effects
(13
)
$
89
Expand
Third Quarter Fiscal 2025 Earnings Conference Call and Webcast Details
Penguin Solutions will hold a conference call and webcast to discuss the third quarter of fiscal 2025 results and related matters today, July 8, 2025, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). Interested parties may access the call by dialing +1-833-470-1428 in the United States or +1-404-975-4839 from international locations, using the access code 305335. The earnings presentation and a live webcast of the conference call can be accessed from the Company's investor relations website (https://ir.penguinsolutions.com/investors/default.aspx) where they will remain available for approximately one year.
Use of Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 that are not historical in nature, that are predictive or that depend upon or refer to future events or conditions. These statements may include, but are not limited to, statements concerning or regarding future events and the future financial and operating performance of Penguin Solutions; statements regarding the extent and timing of and expectations regarding Penguin Solutions' future net sales and expenses; statements regarding Penguin Solutions' strategic objectives and development of our services and capabilities; statements regarding long-term effective tax rates; statements regarding the business and financial outlook for fiscal year 2025 described under 'Business Outlook' above; and statements regarding our liquidity.
These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as 'anticipate,' 'target,' 'expect,' 'estimate,' 'intend,' 'plan,' 'goal,' 'believe,' 'could,' and other words of similar meaning. Forward-looking statements provide our current expectations or forecasts of future events, circumstances, results or aspirations and are subject to a number of significant risks, uncertainties and other factors, many of which are outside of our control, including but not limited to: global business and economic conditions, including the impact on the financial condition of our customers, particularly in challenging macroeconomic environments, growth trends in technology industries (including trends and markets related to artificial intelligence), our customer markets and various geographic regions; uncertainties in the geopolitical environment; the ability to manage our cost structure; disruptions in our operations or supply chain as a result of global pandemics or otherwise; changes in trade regulations and tariffs or adverse developments in international trade relations and agreements; changes in currency exchange rates; overall information technology spending, including changes in customer spending on our products and services; appropriations for government spending; the success of our strategic initiatives including the U.S. Domestication (as defined below) and our ability to realize the anticipated benefits thereof, our rebranding and related strategy, any existing or potential collaborations and additional investments in new products and additional capacity; acquisitions of companies or technologies and the failure to successfully integrate and operate them or customers' negative reactions to them; issues, delays or complications in integrating the operations of Stratus Technologies; failure to achieve the intended benefits of the sale of SMART Brazil and its business; the impact of and expected timing of winding down the manufacturing and discontinuing the sale of products offered through our Penguin Edge business; limitations on or changes in the availability of supply of materials and components; fluctuations in material costs; the temporary or volatile nature of pricing trends in memory or elsewhere; deterioration in customer relationships; our dependence on a select number of customers, and the timing and volume of customer orders and renewals; the impact of customer churn rates, including discounting and churn of significant customers from whom we derive a significant percent of our revenue; production or manufacturing difficulties; competitive factors; technological changes; difficulties with, or delays in, the introduction of new products; slowing or contraction of growth in the memory market, LED market or other markets in which we participate; changes to applicable tax regimes or rates; changes to the valuation allowance for our deferred tax assets, including any potential inability to realize these assets in the future; prices for the end products of our customers; strikes or labor disputes; deterioration in or loss of relations with any of our limited number of key vendors; the inability to maintain or expand government business; and the continuing availability of borrowings under revolving lines of credit or other debt arrangements and our ability to raise capital through debt or equity financings.
These and other risks, uncertainties and factors are described in greater detail under the sections titled 'Risk Factors,' 'Critical Accounting Estimates,' 'Results of Operations,' 'Quantitative and Qualitative Disclosures About Market Risk' and 'Liquidity and Capital Resources' contained in the Annual Report on Form 10-K for the fiscal year ended August 30, 2024 filed prior to the U.S. Domestication by our predecessor Penguin Solutions Cayman (as defined below), as updated by the risk factors contained in our Quarterly Reports on Form 10-Q and in our other filings with the U.S. Securities and Exchange Commission (the 'SEC'). Such risks, uncertainties and factors as outlined above and in such filings could cause our actual results to be materially different from such forward-looking statements. Accordingly, investors are cautioned not to place undue reliance on any forward-looking statements. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we do not undertake to update the forward-looking statements contained in this press release to reflect the impact of circumstances or events that may arise after the date that the forward-looking statements were made.
Statement Regarding Use of Non-GAAP Financial Measures
This press release and the accompanying tables contain the following non-GAAP financial measures: non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP effective tax rate, non-GAAP net income, non-GAAP weighted-average shares outstanding, non-GAAP diluted earnings per share and adjusted EBITDA. Penguin Solutions' management uses these non-GAAP measures to supplement Penguin Solutions' financial results under GAAP. Management uses these measures to analyze its operations and make decisions as to future operational plans and believes that this supplemental non-GAAP information is useful to investors in analyzing and assessing the Company's past and future operating performance. These non-GAAP measures exclude certain items, such as share-based compensation expense; amortization of acquisition-related intangible assets (consisting of amortization of developed technology, customer relationships and trademarks/trade names acquired in connection with business combinations); cost of sales-related restructuring; diligence, acquisition and integration expense; redomiciliation costs; restructuring charges; impairment of goodwill; changes in the fair value of contingent consideration; (gains) losses from changes in foreign currency exchange rates; amortization of debt issuance costs; (gain) loss on extinguishment or prepayment of debt; other infrequent or unusual items and related tax effects and other tax adjustments. While amortization of acquisition-related intangible assets is excluded, the revenues from acquired companies are reflected in the Company's non-GAAP measures and these intangible assets contribute to revenue generation. Management believes the presentation of operating results that exclude certain items provides useful supplemental information to investors and facilitates the analysis of the Company's core operating results and comparison of operating results across reporting periods. Management also uses adjusted EBITDA, which represents GAAP net income (loss), adjusted for net interest expense; income tax provision (benefit); depreciation expense and amortization of intangible assets; share-based compensation expense; cost of sales-related restructuring; diligence, acquisition and integration expense; redomiciliation costs; impairment of goodwill; restructuring charges; loss on extinguishment of debt and other infrequent or unusual items.
In the third quarter of fiscal 2025, for our non-GAAP reporting, we reduced our long-term projected non-GAAP effective tax rate from 28% to 25%, which includes the tax impact of pre-tax non-GAAP adjustments and reflects currently available information as well as other factors and assumptions. This reduction was due to changes in the geographic earnings mix. While we expect to use this normalized non-GAAP effective tax rate through fiscal 2025, this long-term non-GAAP effective tax rate may be subject to change for a variety of reasons, including the rapidly evolving global tax environment, significant changes in our geographic earnings mix or changes to our strategy or business operations. Our GAAP effective tax rate can vary significantly from quarter to quarter based on a variety of factors, including, but not limited to, discrete items which are recorded in the period they occur, the tax effects of certain items of income or expense, significant changes in our geographic earnings mix or changes to our strategy or business operations. We are unable to predict the timing and amounts of these items, which could significantly impact our GAAP effective tax rate, and therefore we are unable to reconcile our forward-looking non-GAAP effective tax rate measure to our GAAP effective tax rate.
Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP, as they exclude important information about Penguin Solutions' financial results, as noted above. The presentation of these adjusted amounts varies from amounts presented in accordance with GAAP and therefore may not be comparable to amounts reported by other companies. In addition, adjusted EBITDA does not purport to represent cash flow provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity. Investors are encouraged to review the 'Reconciliation of GAAP to Non-GAAP Measures' tables below.
Explanatory Note
Subsequent to the end of the third quarter, on June 30, 2025, we completed the redomiciliation of the parent company of our corporate group, Penguin Solutions, Inc., a Cayman Islands exempted company ('Penguin Solutions Cayman'), from the Cayman Islands to the State of Delaware in the United States, resulting in Penguin Solutions, Inc., a Delaware corporation ('Penguin Solutions Delaware'), becoming our publicly traded parent company (the 'U.S. Domestication'). Penguin Solutions Delaware is the successor issuer to Penguin Solutions Cayman. The U.S. Domestication was approved by the shareholders of Penguin Solutions Cayman and effected via a court-sanctioned scheme of arrangement under Cayman Islands law, pursuant to which each ordinary share of Penguin Solutions Cayman was exchanged for one share of common stock of Penguin Solutions Delaware, and each convertible preferred share of Penguin Solutions Cayman was exchanged for one share of convertible preferred stock of Penguin Solutions Delaware. Additional information about the U.S. Domestication was included in Penguin Solutions Cayman's definitive proxy statement on Schedule 14A, filed with the SEC on April 2, 2025. As used in this press release, unless stated otherwise or the context requires otherwise, the terms 'Penguin Solutions,' 'Company,' 'we,' 'our,' 'us' or similar terms (i) for periods prior to the consummation of the U.S. Domestication, refer to Penguin Solutions Cayman and its consolidated subsidiaries and (ii) for periods at or after the consummation of the U.S. Domestication, refer to Penguin Solutions Delaware and its consolidated subsidiaries. Throughout this press release, we refer to our equity securities (i) for periods prior to the consummation of the U.S. Domestication, as ordinary shares and/or convertible preferred shares and (ii) for periods at or after the consummation of the U.S. Domestication, as shares of common stock and/or shares of convertible preferred stock.
About Penguin Solutions
The most exciting technological advancements are also the most challenging for companies to adopt. At Penguin Solutions, we support our customers in achieving their ambitions across our Advanced Computing, Integrated Memory, and Optimized LED lines of business. With our expert skills, experience, and partnerships, we turn our customers' most complex challenges into compelling opportunities.
For more information, visit www.penguinsolutions.com.
Penguin Solutions, Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands, except percentages)
(Unaudited)
Three Months Ended
Nine Months Ended
May 30,
2025
Feb. 28,
2025
May 31,
2024
May 30,
2025
May 31,
2024
GAAP gross profit
$
95,083
$
104,648
$
88,906
$
297,543
$
253,690
Share-based compensation expense
1,393
1,776
1,760
4,812
5,266
Amortization of acquisition-related intangibles
5,908
5,907
5,909
17,724
17,747
Cost of sales-related restructuring
369
77
387
404
1,271
Other
—
—
—
(200
)
—
Non-GAAP gross profit
$
102,753
$
112,408
$
96,962
$
320,283
$
277,974
GAAP gross margin
29.3
%
28.6
%
29.6
%
28.9
%
29.5
%
Effect of adjustments
2.4
%
2.2
%
2.7
%
2.2
%
2.8
%
Non-GAAP gross margin
31.7
%
30.8
%
32.3
%
31.1
%
32.3
%
GAAP operating expenses
$
85,240
$
86,160
$
77,395
$
251,856
$
244,186
Share-based compensation expense
(8,858
)
(9,804
)
(9,432
)
(28,550
)
(27,535
)
Amortization of acquisition-related intangibles
(2,531
)
(2,932
)
(3,857
)
(9,309
)
(11,778
)
Diligence, acquisition and integration expense
(296
)
(567
)
(4
)
(1,696
)
(6,678
)
Redomiciliation costs (1)
(3,702
)
(2,359
)
—
(7,304
)
—
Impairment of goodwill
(5,294
)
(6,079
)
—
(11,373
)
—
Restructuring charges
—
(859
)
(465
)
(968
)
(6,739
)
Other (1)
(280
)
(242
)
—
(855
)
—
Non-GAAP operating expenses
$
64,279
$
63,318
$
63,637
$
191,801
$
191,456
GAAP operating income
$
9,843
$
18,488
$
11,511
$
45,687
$
9,504
Share-based compensation expense
10,251
11,580
11,192
33,362
32,801
Amortization of acquisition-related intangibles
8,439
8,839
9,766
27,033
29,525
Cost of sales-related restructuring
369
77
387
404
1,271
Diligence, acquisition and integration expense
296
567
4
1,696
6,678
Redomiciliation costs (1)
3,702
2,359
—
7,304
—
Impairment of goodwill
5,294
6,079
—
11,373
—
Restructuring charges
—
859
465
968
6,739
Other (1)
280
242
—
655
—
Non-GAAP operating income
$
38,474
$
49,090
$
33,325
$
128,482
$
86,518
(1) In the second quarter of fiscal 2025 we began breaking out redomiciliation costs from 'Other.' All periods presented have been adjusted to reflect this change.
Expand
Penguin Solutions, Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
Nine Months Ended
May 30,
2025
Feb. 28,
2025
May 31,
2024
May 30,
2025
May 31,
2024
GAAP net income (loss) attributable to Penguin Solutions
$
2,661
$
8,082
$
5,616
$
15,960
$
(19,777
)
Share-based compensation expense
10,251
11,580
11,192
33,362
32,801
Amortization of acquisition-related intangibles
8,439
8,839
9,766
27,033
29,525
Cost of sales-related restructuring
369
77
387
404
1,271
Diligence, acquisition and integration expense
296
567
4
1,696
6,678
Redomiciliation costs (1)
3,702
2,359
—
7,304
—
Impairment of goodwill
5,294
6,079
—
11,373
—
Restructuring charges
—
859
465
968
6,739
Amortization of debt issuance costs
916
950
817
2,819
2,827
Loss (gain) on extinguishment or prepayment of debt
—
—
792
—
1,117
Foreign currency (gains) losses
(1,134
)
24
606
(82
)
242
Other (1)
280
242
—
655
—
Income tax effects
54
(5,822
)
(9,424
)
(10,010
)
(14,523
)
Non-GAAP net income attributable to Penguin Solutions
31,128
33,836
20,221
91,482
46,900
Preferred share dividends
3,033
2,600
—
5,633
—
Non-GAAP income available for distribution
28,095
31,236
20,221
85,849
50,108
Income allocated to participating securities
2,863
2,706
—
5,545
—
$
25,232
$
28,530
$
20,221
$
80,304
$
50,108
Weighted-average shares outstanding - Diluted:
GAAP weighted-average shares outstanding
53,738
54,384
54,283
54,336
52,219
Adjustment for dilutive securities and capped calls
—
—
(333
)
—
1,216
Non-GAAP weighted-average shares outstanding
53,738
54,384
53,950
54,336
53,435
Diluted earnings (loss) per share from continuing operations:
GAAP diluted earnings (loss) per share
$
(0.01
)
$
0.09
$
0.10
$
0.18
$
(0.38
)
Effect of adjustments
0.48
0.43
0.27
1.30
1.26
Non-GAAP diluted earnings per share
$
0.47
$
0.52
$
0.37
$
1.48
$
0.88
Net income (loss) attributable to Penguin Solutions
$
2,661
$
8,082
$
5,616
$
15,960
$
(19,777
)
Interest expense, net
573
2,183
6,167
7,152
22,975
Income tax provision (benefit)
7,259
7,643
(1,323
)
21,262
4,409
Depreciation expense and amortization of intangible assets
14,012
14,037
15,525
43,010
50,335
Share-based compensation expense
10,251
11,580
11,192
33,362
32,801
Cost of sales-related restructuring
369
77
387
404
1,271
Diligence, acquisition and integration expense
296
567
4
1,696
6,678
Redomiciliation costs (1)
3,702
2,359
—
7,304
—
Impairment of goodwill
5,294
6,079
—
11,373
—
Restructuring charges
—
859
465
968
6,739
Loss on extinguishment of debt
—
—
792
—
1,117
Other (1)
280
242
—
655
—
Adjusted EBITDA
$
44,697
$
53,708
$
38,825
$
143,146
$
106,548
(1) In the second quarter of fiscal 2025 we began breaking out redomiciliation costs from 'Other.' All periods presented have been adjusted to reflect this change.
Expand
Penguin Solutions, Inc.
Consolidated Balance Sheets
(In thousands)
(Unaudited)
As of
May 30,
2025
August 30,
2024
Assets
Cash and cash equivalents
$
709,871
$
383,147
Short-term investments
25,676
6,337
Accounts receivable, net
292,504
251,743
Inventories
184,348
151,213
Other current assets
37,497
75,264
Total current assets
1,249,896
867,704
Property and equipment, net
93,882
106,548
Operating lease right-of-use assets
61,850
60,349
Intangible assets, net
95,130
121,454
Goodwill
150,585
161,958
Deferred tax assets
83,872
85,078
Other noncurrent assets
67,567
71,415
Total assets
$
1,802,782
$
1,474,506
Liabilities and Equity
Accounts payable and accrued expenses
$
310,572
$
219,090
Current debt
19,916
—
Deferred revenue
101,374
63,954
Other current liabilities
44,882
44,552
Total current liabilities
476,744
327,596
Long-term debt
639,562
657,347
Noncurrent operating lease liabilities
63,650
60,542
Other noncurrent liabilities
27,903
29,813
Total liabilities
1,207,859
1,075,298
Commitments and contingencies
Penguin Solutions shareholders' equity:
Ordinary shares
1,869
1,807
Preferred shares
6
—
Additional paid-in capital
745,557
513,335
Retained earnings
40,312
29,985
Treasury shares
(202,996
)
(153,756
)
Accumulated other comprehensive income
23
10
Total Penguin Solutions shareholders' equity
584,771
391,381
Noncontrolling interest in subsidiary
10,152
7,827
Total equity
594,923
399,208
Total liabilities and equity
$
1,802,782
$
1,474,506
Expand
Penguin Solutions, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine Months Ended
May 30,
2025
Feb. 28,
2025
May 31,
2024
May 30,
2025
May 31,
2024
Cash flows from operating activities
Net income (loss)
$
3,450
$
8,871
$
6,226
$
18,285
$
(26,141
)
Net loss from discontinued operations
—
—
—
—
(8,148
)
Net income (loss) from continuing operations
3,450
8,871
6,226
18,285
(17,993
)
Adjustments to reconcile net income (loss) from continuing operations to cash provided by (used for) operating activities
Depreciation expense and amortization of intangible assets
14,012
14,037
15,525
43,010
50,335
Amortization of debt issuance costs
917
950
817
2,820
2,827
Share-based compensation expense
10,251
11,580
11,192
33,362
32,801
Impairment of goodwill
5,294
6,079
—
11,373
—
Loss on extinguishment or prepayment of debt
—
—
792
—
1,117
Deferred income taxes, net
959
(48
)
(3,840
)
1,122
(3,646
)
Other
(1,041
)
(716
)
(3,228
)
(2,469
)
(2,772
)
Changes in operating assets and liabilities:
Accounts receivable
37,880
(54,755
)
(42,124
)
(40,760
)
7,406
Inventories
15,389
47,215
(4,535
)
(30,776
)
(2,321
)
Other assets
(1,979
)
15,015
15,424
13,741
(5,703
)
Accounts payable and accrued expenses and other liabilities
11,788
24,649
83,632
133,908
84,626
Payment of acquisition-related contingent consideration
—
—
—
—
(29,000
)
Net cash provided by operating activities from continuing operations
96,920
72,877
79,881
183,616
117,677
Net cash used for operating activities from discontinued operations
(4,099
)
—
(101
)
(4,099
)
(28,336
)
Net cash provided by operating activities
92,821
72,877
79,780
179,517
89,341
Cash flows from investing activities
Capital expenditures and deposits on equipment
(1,916
)
(2,335
)
(3,777
)
(6,087
)
(13,629
)
Proceeds from maturities of investment securities
12,650
11,055
9,915
27,485
31,870
Purchases of held-to-maturity investment securities
(12,733
)
(12,671
)
—
(46,127
)
(19,503
)
Purchases of non-marketable investments
—
—
(1,000
)
—
(1,000
)
Other
(474
)
(398
)
(518
)
(1,015
)
(1,264
)
Net cash used for investing activities from continuing operations
(2,473
)
(4,349
)
4,620
(25,744
)
(3,526
)
Net cash provided by investing activities from discontinued operations
28,350
—
451
28,350
119,389
Net cash provided by (used for) investing activities
$
25,877
$
(4,349
)
$
5,071
$
2,606
$
115,863
Expand
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Stock market today: Nasdaq, Dow, S&P 500, Nasdaq futures jump as Big Tech earnings, trade deals lift spirits
S&P 500 and Nasdaq futures surged on Thursday, setting sights on fresh record highs after strong Meta (META) and Microsoft (MSFT) earnings boosted faith in a payoff from Big Tech's massive AI investments. Contracts on the tech-heavy Nasdaq 100 (NQ=F) climbed roughly 1.4%, while those on the S&P 500 (ES=F) rose almost 1%. Dow Jones Industrial Average futures (YM=F) lagged, up 0.3%. Meta shares shot up 12% in premarket, as investors welcomed its earnings beat and stronger-than-expected guidance even as it ramps up its AI spending spree. Microsoft stock jumped over 8% after its impressive results, on track to make the company the second in the world to reach a $4 trillion market valuation. Markets are now looking to after-hours results from their "Magnificent Seven" peers Apple (AAPL) and Amazon (AMZN) for reasons to keep the rally going. On the macro front, investors will get another clue as to the possible direction of interest rates with the release of the Federal Reserve's preferred inflation gauge, the Personal Consumption Expenditures (PCE) index. Stocks were mixed in during the day Wednesday after the Fed held interest rates steady for its fifth-straight meeting, with two Fed governors dissenting. Following the decision, Fed Chair Jerome Powell stressed "no decisions" had been made about a September rate cut, undercutting President Trump's claim he had heard a cut was coming at policymakers' next meeting.. Meanwhile a flurry of trade deals eased trade-war fears on the eve of President Trump's deadline on Friday. A pact with South Korea announced late Wednesday sets a 15% tariff rate on its imports. US exports will face zero duties in return, and Seoul has agreed to make $350 billion in US investment and pledged to buy US energy products, Trump wrote in a social media post. A quirk in the Fed's calendar puts extra pressure on the Sept. meeting Yahoo Finance's Hamza Shaban takes a look at the Federal Reserve's next move in today's Morning Brief: Read more here on how a long wait could result in a different outlook. Good morning. Here's what's happening today. Economic data: Challenger jobs cuts (July); Personal income & spending (June); Core PCE price index; Employment cost index (second quarter); Initial jobless claims (week ending July 26) Earnings: Apple (AAPL), Amazon (AMZN), Bristol Myers Squibb (BMY), Cigna (CI), Coinbase (COIN), CVS Health (CVS), Mastercard (MA), Norwegian Cruise Line (NCLH), Reddit (RDDT), Roblox (RBLX), Roku (ROKU), Strategy (MSTR) Here are some of the biggest stories you may have missed overnight and early this morning: Trump knocks Canada as countries rush to strike trade deals Trump tariffs face another legal test on eve of deadline Apple faces 2 major threats ahead of earnings What's in the US-EU trade deal? It depends on who's talking. Fed calendar quirk raises the stakes for its Sept. meeting Meta stock surges after earnings beat, guidance surprise Microsoft on track for $4 trillion market cap after earnings beat Arm stock falls as chip ambitions shake investor confidence Trending tickers: ARM, CVS and Confluent Here are some top stocks trending on Yahoo Finance in premarket trading: Arm (ARM) stock fell 6% on Thursday before the bell following the announcement of the chip tech provider's plan to invest in its own chip development, which would bite into future profits, disappointed investors. CVS (CVS) stock jumped 7% in premarket on Thursday after the company beat Wall Street estimates for second-quarter profit. Confluent Inc (CFLT) stock rose over 20% premarket following the company's positive earnings report. The data streaming platform reported a 21% growth in subscription revenue and a 28% growth in Confluent Cloud revenue for Q2 2025. Carvana posts higher quarterly profit on record car sales Shares in Carvana (CVNA) surged over 15% in premarket trading after the online used-car seller defied expectations with strong second quarter results and outlook. Bloomberg reports: Read more here. EBay stock rises as resilient consumers fuel strong sales forecast EBay (EBAY) stock jumped on Thursday before the bell after the e-commerce company forecasted sales that topped analysts' estimates, suggesting optimism for continued consumer resilience at a time of shifting US tariff proposals. Bloomberg News reports: Read more here. AB InBev shares slide on concern over sales volumes Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares. Reuters reports: Read more here. Qualcomm on the move lower Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket. The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now. This note from HSBC's Ryan Mellor this morning captures it all nicely: This is remarkable on Meta Meta's (META) stock is rocking higher in premarket, to the tune of 12% after a monster quarter. Got to love the market ignoring the capex stuff in its earnings release below, and focusing in on Meta's revenue trends (strong). "We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations," Meta said. Bottom line: bull market ... carry on! Microsoft earnings call: A quick take A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical Satya Nadella tech jargon. Bottom line is this: Azure sales crushed, and there was zero signs of peaking AI demand. That should be good enough for the bulls. "We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said. Samsung Electronics chip business fell drastically in Q2 Samsung Electronics ( saw a mammoth drop in profit from the chip-making arm of the electronics giant. Bloomberg reports: Read more here. A quirk in the Fed's calendar puts extra pressure on the Sept. meeting Yahoo Finance's Hamza Shaban takes a look at the Federal Reserve's next move in today's Morning Brief: Read more here on how a long wait could result in a different outlook. Yahoo Finance's Hamza Shaban takes a look at the Federal Reserve's next move in today's Morning Brief: Read more here on how a long wait could result in a different outlook. Good morning. Here's what's happening today. Economic data: Challenger jobs cuts (July); Personal income & spending (June); Core PCE price index; Employment cost index (second quarter); Initial jobless claims (week ending July 26) Earnings: Apple (AAPL), Amazon (AMZN), Bristol Myers Squibb (BMY), Cigna (CI), Coinbase (COIN), CVS Health (CVS), Mastercard (MA), Norwegian Cruise Line (NCLH), Reddit (RDDT), Roblox (RBLX), Roku (ROKU), Strategy (MSTR) Here are some of the biggest stories you may have missed overnight and early this morning: Trump knocks Canada as countries rush to strike trade deals Trump tariffs face another legal test on eve of deadline Apple faces 2 major threats ahead of earnings What's in the US-EU trade deal? It depends on who's talking. Fed calendar quirk raises the stakes for its Sept. meeting Meta stock surges after earnings beat, guidance surprise Microsoft on track for $4 trillion market cap after earnings beat Arm stock falls as chip ambitions shake investor confidence Economic data: Challenger jobs cuts (July); Personal income & spending (June); Core PCE price index; Employment cost index (second quarter); Initial jobless claims (week ending July 26) Earnings: Apple (AAPL), Amazon (AMZN), Bristol Myers Squibb (BMY), Cigna (CI), Coinbase (COIN), CVS Health (CVS), Mastercard (MA), Norwegian Cruise Line (NCLH), Reddit (RDDT), Roblox (RBLX), Roku (ROKU), Strategy (MSTR) Here are some of the biggest stories you may have missed overnight and early this morning: Trump knocks Canada as countries rush to strike trade deals Trump tariffs face another legal test on eve of deadline Apple faces 2 major threats ahead of earnings What's in the US-EU trade deal? It depends on who's talking. Fed calendar quirk raises the stakes for its Sept. meeting Meta stock surges after earnings beat, guidance surprise Microsoft on track for $4 trillion market cap after earnings beat Arm stock falls as chip ambitions shake investor confidence Trending tickers: ARM, CVS and Confluent Here are some top stocks trending on Yahoo Finance in premarket trading: Arm (ARM) stock fell 6% on Thursday before the bell following the announcement of the chip tech provider's plan to invest in its own chip development, which would bite into future profits, disappointed investors. CVS (CVS) stock jumped 7% in premarket on Thursday after the company beat Wall Street estimates for second-quarter profit. Confluent Inc (CFLT) stock rose over 20% premarket following the company's positive earnings report. The data streaming platform reported a 21% growth in subscription revenue and a 28% growth in Confluent Cloud revenue for Q2 2025. Here are some top stocks trending on Yahoo Finance in premarket trading: Arm (ARM) stock fell 6% on Thursday before the bell following the announcement of the chip tech provider's plan to invest in its own chip development, which would bite into future profits, disappointed investors. CVS (CVS) stock jumped 7% in premarket on Thursday after the company beat Wall Street estimates for second-quarter profit. Confluent Inc (CFLT) stock rose over 20% premarket following the company's positive earnings report. The data streaming platform reported a 21% growth in subscription revenue and a 28% growth in Confluent Cloud revenue for Q2 2025. Carvana posts higher quarterly profit on record car sales Shares in Carvana (CVNA) surged over 15% in premarket trading after the online used-car seller defied expectations with strong second quarter results and outlook. Bloomberg reports: Read more here. Shares in Carvana (CVNA) surged over 15% in premarket trading after the online used-car seller defied expectations with strong second quarter results and outlook. Bloomberg reports: Read more here. EBay stock rises as resilient consumers fuel strong sales forecast EBay (EBAY) stock jumped on Thursday before the bell after the e-commerce company forecasted sales that topped analysts' estimates, suggesting optimism for continued consumer resilience at a time of shifting US tariff proposals. Bloomberg News reports: Read more here. EBay (EBAY) stock jumped on Thursday before the bell after the e-commerce company forecasted sales that topped analysts' estimates, suggesting optimism for continued consumer resilience at a time of shifting US tariff proposals. Bloomberg News reports: Read more here. AB InBev shares slide on concern over sales volumes Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares. Reuters reports: Read more here. Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares. Reuters reports: Read more here. Qualcomm on the move lower Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket. The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now. This note from HSBC's Ryan Mellor this morning captures it all nicely: Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket. The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now. This note from HSBC's Ryan Mellor this morning captures it all nicely: This is remarkable on Meta Meta's (META) stock is rocking higher in premarket, to the tune of 12% after a monster quarter. Got to love the market ignoring the capex stuff in its earnings release below, and focusing in on Meta's revenue trends (strong). "We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations," Meta said. Bottom line: bull market ... carry on! Meta's (META) stock is rocking higher in premarket, to the tune of 12% after a monster quarter. Got to love the market ignoring the capex stuff in its earnings release below, and focusing in on Meta's revenue trends (strong). "We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations," Meta said. Bottom line: bull market ... carry on! Microsoft earnings call: A quick take A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical Satya Nadella tech jargon. Bottom line is this: Azure sales crushed, and there was zero signs of peaking AI demand. That should be good enough for the bulls. "We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said. A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical Satya Nadella tech jargon. Bottom line is this: Azure sales crushed, and there was zero signs of peaking AI demand. That should be good enough for the bulls. "We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said. Samsung Electronics chip business fell drastically in Q2 Samsung Electronics ( saw a mammoth drop in profit from the chip-making arm of the electronics giant. Bloomberg reports: Read more here. Samsung Electronics ( saw a mammoth drop in profit from the chip-making arm of the electronics giant. Bloomberg reports: Read more here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates
CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its second quarter 2025 financial results and operational highlights in a conference call on August 7, 2025, at 8 a.m. ET. To join the call: U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the call. All participants should ask to be connected to the Intellia Therapeutics conference call. Please visit this link for a simultaneous live webcast of the call. A replay of the call will be available through the Events and Presentations page of the Investors & Media section on Intellia's website at beginning on August 7, 2025, at 12 p.m. ET. About Intellia Therapeutics Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Since its inception, Intellia has focused on leveraging gene editing technology to develop novel, first-in-class medicines that address important unmet medical needs and advance the treatment paradigm for patients. Intellia's deep scientific, technical and clinical development experience, along with its people, is helping set the standard for a new class of medicine. To harness the full potential of gene editing, Intellia continues to expand the capabilities of its CRISPR-based platform with novel editing and delivery technologies. Learn more at and follow us @ ChavesSenior Manager, Investor
Yahoo
19 minutes ago
- Yahoo
Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025
CHICAGO, July 31, 2025--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that the Company will release its second quarter 2025 financial results before the open of the U.S. financial markets on Thursday, August 7, 2025. Management will host a conference call and webcast at 8:30 a.m. Eastern Time that day to discuss the Company's financial and operational results. To pre-register for the call, please go to the following link: After registering, a confirmation email will be sent, including dial-in details and a unique code for entry. The Company recommends registering a minimum of ten minutes prior to the start of the call. Following the conference call, a replay will be available until Thursday, August 21, 2025 at US:1 929 458 6194, US Toll Free: 1 866 813 9403, UK: 0204 525 0658, Canada: 1 226 828 7578, or all other locations: +44 204 525 0658 Access Code: 520958. To join the webcast, please visit "Events" on investor relations page of the Company's website at or use this link: About Xeris Xeris (Nasdaq: XERS) is a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products: Recorlev®, for the treatment of endogenous Cushing's syndrome; Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia, and a gastrointestinal motility inhibitor when used during radiology exams as a diagnostic aid; and Keveyis®, a proven therapy for primary periodic paralysis. Xeris also has a pipeline of development programs led by XP-8121, a Phase 3-ready, once-weekly subcutaneous injection for the treatment of hypothyroidism, as well as multiple early-stage programs leveraging Xeris' technology platforms, XeriSol® and XeriJect®, for its partners. Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit or follow us on X, LinkedIn, or Instagram. View source version on Contacts Xeris Investor Contact Allison WeySenior Vice President, Investor Relations and Corporate Communicationsawey@ Sign in to access your portfolio